Cargando…
A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma
BACKGROUND: The aim of this study was to examine the efficacy and safety of everolimus in patients with progressive unresectable adenoid cystic carcinoma (ACC). METHODS: Histologically confirmed ACC patients with documented disease progression within 12 months prior to the study entry were eligible....
Autores principales: | Kim, Dong-Wan, Oh, Do-Youn, Shin, Seong Hoon, Kang, Jin Hyoung, Cho, Byoung Chul, Chung, Joo-Seop, Kim, HyeJin, Park, Keon Uk, Kwon, Jung Hye, Han, Ji-Youn, Kim, Mi-Jung, Bang, Yung-Jue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228069/ https://www.ncbi.nlm.nih.gov/pubmed/25362970 http://dx.doi.org/10.1186/1471-2407-14-795 |
Ejemplares similares
-
Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma
por: Ha, Hyerim, et al.
Publicado: (2021) -
Prognostic Significance of Nuclear Survivin Expression in Resected Adenoid Cystic Carcinoma of the Head and Neck
por: Ko, Yoon Ho, et al.
Publicado: (2010) -
Human Papillomavirus Infection–Associated Adenoid Cystic Carcinoma of the Hard Palate
por: Chung, Arthur Minwoo, et al.
Publicado: (2017) -
Rapid response to radiotherapy in unresectable tracheal adenoid cystic carcinoma: A case report
por: Wu, Qiang, et al.
Publicado: (2021) -
Male Breast Adenoid Cystic Carcinoma
por: Yoo, Seung Jin, et al.
Publicado: (2013)